Rectal Cancer Treatment Regimens
Get the latest treatment options for rectal cancer, including concurrent chemotherapy and radiotherapy and levoleucovorin plus 5-FU.
Rectal Cancer
Comparing Long-Course Chemoradiation With Short-Course Radiation Therapy in Rectal Cancer
Early results from the Polish II study showed a significant improvement in OS for preoperative short-course RT/chemotherapy compared with long-term chemo-RT.
Adherence to Topical Management of Hand-Foot Skin Reaction Poor Among Patients Treated With Regorafenib
Researchers sought to measure adherence to topical management regimens among patients with HFSR due to treatment with regorafenib.
Guideline Recommendations Offer No OS Benefit for Younger Patients With Rectal Cancer
A retrospective review of data from the National Cancer Data Base demonstrated that trends in rectal cancer may follow a pattern similar to that of colon cancer.
Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
Incidence of colon and rectal cancers are increasing sharply in people younger than 50 years, the recommended age for initiating screening.
Short-Course Radiation With Delay to Surgery Improves Outcomes in Rectal Cancer
Outcomes improved with short-course radiation and delay to surgery of 4 to 8 weeks.
Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
In this study, the impact of advancements in surgical technique and systemic therapy for stage II and III rectal cancers was assessed via a comparison of outcomes after neoadjuvant chemoradiotherapy followed by definitive resection with those for neoadjuvant multiagent chemotherapy without radiation therapy.
Poor Compliance to Adjuvant Chemo Linked to Poorer Survival in Rectal Cancer
Poor compliance to NCCN guidelines for adjuvant chemotherapy appears to be associated with poorer overall survival.
Substantial Increase in Use of Neoadjuvant Chemoradiotherapy for Rectal Cancer
Use of neoadjuvant chemoradiotherapy (NACRT) before surgery among patients with rectal cancer has substantially increased over the past decade.
Nonoperative Management of Rectal Adenocarcinoma Examined
Nearly 50% of patients with stage II/III rectal cancer achieve a complete clinical response via neoadjuvant chemoradiation.
Next post in Daily Oncology News
